中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2015年
16期
103-104,107
,共3页
持续静滴氨茶碱%异丙托溴铵%COPD急性加重期%临床疗效
持續靜滴氨茶堿%異丙託溴銨%COPD急性加重期%臨床療效
지속정적안다감%이병탁추안%COPD급성가중기%림상료효
Continuous infusion of aminophylline%Ipratropium bromide%Acute exacerbation of COPD%Clinical curative effect
目的:探究慢性阻塞性肺疾病COPD急性加重期患者应用持续静滴氨茶碱联合异丙托溴铵治疗的临床效果和特点,以提高其治疗水平。方法从该院2012年4月-2014年6月接收并治疗的慢性阻塞性肺疾病急性加重期患者中随机性抽取80例进行回顾性分析和探究,并根据入院就诊顺序随机分为对照组和研究组,每组40例。对照组采用持续静滴氨茶碱进行治疗,研究组静滴氨茶碱搭配异丙托溴铵治疗。观察FEV1%、FEV1/FVC和PaO2值等指标。结果研究组患者治疗后FEV1%预计值为(65.3±18.3)、FEV1/FVC值为(59.8±19.5)对照组患者治疗后FEV1%预计值为(55.6±15.4)、FEV1/FVC值为(56.5±18.7),两组经对比,差异有统计学意义(P<0.05),同时PaO2值明显上升,PaCO2明显下降。结论针对慢性阻塞性肺疾病COPD急性加重期患者采用无创呼吸机治疗的基础上,持续静滴氨茶碱联合异丙托溴铵治疗,不仅可以降氨茶碱低不良反应的发生率,还可以提高治疗效果,值得在临床治疗中广泛运用。
目的:探究慢性阻塞性肺疾病COPD急性加重期患者應用持續靜滴氨茶堿聯閤異丙託溴銨治療的臨床效果和特點,以提高其治療水平。方法從該院2012年4月-2014年6月接收併治療的慢性阻塞性肺疾病急性加重期患者中隨機性抽取80例進行迴顧性分析和探究,併根據入院就診順序隨機分為對照組和研究組,每組40例。對照組採用持續靜滴氨茶堿進行治療,研究組靜滴氨茶堿搭配異丙託溴銨治療。觀察FEV1%、FEV1/FVC和PaO2值等指標。結果研究組患者治療後FEV1%預計值為(65.3±18.3)、FEV1/FVC值為(59.8±19.5)對照組患者治療後FEV1%預計值為(55.6±15.4)、FEV1/FVC值為(56.5±18.7),兩組經對比,差異有統計學意義(P<0.05),同時PaO2值明顯上升,PaCO2明顯下降。結論針對慢性阻塞性肺疾病COPD急性加重期患者採用無創呼吸機治療的基礎上,持續靜滴氨茶堿聯閤異丙託溴銨治療,不僅可以降氨茶堿低不良反應的髮生率,還可以提高治療效果,值得在臨床治療中廣汎運用。
목적:탐구만성조새성폐질병COPD급성가중기환자응용지속정적안다감연합이병탁추안치료적림상효과화특점,이제고기치료수평。방법종해원2012년4월-2014년6월접수병치료적만성조새성폐질병급성가중기환자중수궤성추취80례진행회고성분석화탐구,병근거입원취진순서수궤분위대조조화연구조,매조40례。대조조채용지속정적안다감진행치료,연구조정적안다감탑배이병탁추안치료。관찰FEV1%、FEV1/FVC화PaO2치등지표。결과연구조환자치료후FEV1%예계치위(65.3±18.3)、FEV1/FVC치위(59.8±19.5)대조조환자치료후FEV1%예계치위(55.6±15.4)、FEV1/FVC치위(56.5±18.7),량조경대비,차이유통계학의의(P<0.05),동시PaO2치명현상승,PaCO2명현하강。결론침대만성조새성폐질병COPD급성가중기환자채용무창호흡궤치료적기출상,지속정적안다감연합이병탁추안치료,불부가이강안다감저불량반응적발생솔,환가이제고치료효과,치득재림상치료중엄범운용。
Objective To explore the clinical effect of continuous infusion of aminophylline combined with ipratropium bromide in the treatment of acute exacerbation of COPD so as to improve the treatment level. Methods Our hospital between April 2012 and June 2012, receiving and treatment of chronic obstructive pulmonary disease patients with acute aggravating period of random sampling, 80 cases were analyzed retrospectively and to explore, and according to the hospital seeing a doctor order were randomly divided into control group and research group, 40 cases in each group. Results Group after treatment in patients with FEV1 % is expected to rise in value, FEV1 / FVC, PaO2 value rise significantly, PaCO2 decreased obviously. Conclusion for patients with COPD exacerbations of chronic obstructive pulmonary disease period, on the basis of using noninvasive ventilator therapy, continu-ous static drops of aminophylline combined isopropyl bromide treatment, not only can reduce the incidence rate of adverse reac-tion, also can improve the treatment effect, is widely used in clinical treatment.